Results of the ROTAVAC Rotavirus Vaccine Study in IndiaStatement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
Vince and Associates Clinical Research Joins the Altasciences GroupThe Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities.
Cocaine Vaccine Passes Key Testing HurdleNew anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon.
Redx Pharma Opens £10.5 Million R&D Centre in UKLiverpool-based drug discovery and development company Redx Pharma is to open a new research and development facility at AZ's Alderley Park site in Cheshire.
NIH Clinical Trial Begins for Treatment of Rare, Fatal Neurological DisorderGovernment, industry, academia, and patient groups collaborate on Niemann-Pick Type C research.
NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage TrialThe trial results appeared in the April 1 issue of the Journal of Infectious Diseases.
Galapagos Discovers Novel Candidate Drug to Treat Breast CancerGLPG1790 has high efficacy against triple-negative breast cancer.
Genticel Announces Positive Data from Phase I Trial in HPV Infected WomenFirst ever trial to recruit HPV infected women with no cervical lesions.
Nanosponges can Remove Toxins from BloodstreamEngineers have invented a “nanosponge” capable of safely removing a broad class of dangerous toxins from the bloodstream.
Results from C3BS C-CURE® Trial Published in the Journal of the ACCTrial demonstrates statistically significant improvements in heart function and exercise tolerance with cardiopoietic stem cell therapy.
